Difluorocarbene radiosynthesis
US-2024383827-A1 · Nov 21, 2024 · US
US10112901B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10112901-B2 |
| Application number | US-201415323709-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 3, 2014 |
| Priority date | Jul 3, 2014 |
| Publication date | Oct 30, 2018 |
| Grant date | Oct 30, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are a method for preparing a dabigatran etexilate intermediate, and an intermediate compound. The method for preparing a dabigatran etexilate intermediate 4 comprises: reacting a compound 3 with a C 1 -C 3 alkyl alcohol solution of methylamine in an organic solvent, wherein, X=chlorine, bromine, or iodine. Also disclosed are an intermediate compound 3 and a preparation method thereof. The method for preparing a dabigatran etexilate intermediate of the present invention has the advantages of simple process, easy operation, high yield, and easy purification, thus being suitable for industrial production.
Opening claim text (preview).
What is claimed is: 1. A preparation method of a dabigatran etexilate intermediate 4, comprising: reacting a compound 3 with a C 1 -C 3 alkyl alcohol solution of methylamine in an organic solvent, wherein the organic solvent is a erotic organic solvent or an aprotic organic solvent; and wherein, X=chlorine, bromine, or iodine. 2. The preparation method according to claim 1 , wherein the protic organic solvent is methanol and/or ethanol, and the aprotic organic solvent is an aprotic polar organic solvent. 3. The preparation method according to claim 2 , wherein the aprotic organic solvent is one or more of dimethyl sulfoxide, N,N-dimethyl formamide, N,N-dimethyl acetamide, and N-methyl pyrrolidone. 4. The preparation method according to claim 1 , wherein the C 1 -C 3 alkyl alcohol solution of methylamine is one or more of a methanol solution of methylamine, an ethanol solution of methylamine, and a propanol solution of methylamine; and the concentration of the C 1 -C 3 alkyl alcohol solution of methylamine is 27-32% by weight. 5. The preparation method according to claim 1 , wherein the molar ratio of the compound 3 to methylamine is 1:1.98-1:2.35. 6. The preparation method according to claim 1 , wherein the C 1 -C 3 alkyl alcohol solution of methylamine is added by dripping the C alkyl alcohol solution of methylamine into a mixture of the compound 3 and the organic solvent. 7. The preparation method according to claim 1 , wherein when the organic solvent is a prone organic solvent, the reaction temperature is 30-40° C.; and when the organic solvent is an aprotic organic solvent, the reaction temperature is 60-90° C. 8. The preparation method according to claim 7 , wherein when the organic solvent is an aprotic organic solvent, the reaction temperature is 70° C. 9. The preparation method according to claim 1 , wherein the compound 3 is prepared through a method comprising: acylating a compound 2 with ethyl 3-(pyridin-2-yl-amino)propionate in dichloromethane and/or tetrahydrofuran in the presence of an organic base; and then the dabigatran etexilate intermediate 4 is prepared following the preparation method according to claim 1 , wherein, X=chlorine, bromine, or iodine. 10. The preparation method according to claim 9 , wherein the organic base is triethylamine and/or N,N-diisopropylethylamine. 11. The preparation method according to claim 9 , wherein the molar ratio of the compound 2 to ethyl 3-(pyridin-2-yl-amino)propionate is 1:1; the molar ratio of the organic base to the compound 2 is 1:1-2:1; and the acylation temperature is 0-30° C. 12. The preparation method according to claim 9 , wherein the volume/weight ratio of dichloromethane and/or tetrahydrofuran to the compound 2 is 4-7 ml/g. 13. The preparation method according to claim 9 , wherein the compound 2 is added by dripping a mixture of the compound 2 and dichloromethane and/or tetrahydrofuran into a mixture of ethyl 3-(pyridin-2-yl-amino)propionate and the organic base. 14. A compound having a structure represented by wherein, X=chlorine, bromine, or iodine. 15. A preparation method of the compound 3, represented by: the preparation method comprising: acylating a compound 2 with ethyl 3-(pyridin-2-yl-amino)propionate in dichloromethane and/or tetrahydrofuran in the presence of an organic base, wherein, X=chlorine, bromine, or iodine; and the reaction conditions in the preparation method are as defined in claim 9 .
Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.